Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleKinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.AuthorsAlfarsi, Lutfi H.; Elansari, Rokaya; Toss, Michael S.; Diez-Rodriguez, Maria; Nolan, Christopher C.; Ellis, Ian O.; Rakha, Emad A.; Green, Andrew R.PublicationBreast Cancer Research & Treatment, 2019, Vol 173, Issue 1, p93ISSN0167-6806Publication typeArticleDOI10.1007/s10549-018-4978-5